SCD14-ST and New Generation Inflammatory Biomarkers in the Prediction of COVID-19 Outcome
Since no definitive cure for COVID-19 is available so far, one of the challenges against the disease is understanding the clinical features and the laboratory inflammatory markers that can differentiate among different severity grades of the disease. The aim of the present study is a comprehensive a...
Main Authors: | Emanuela Galliera, Luca Massaccesi, Lina Yu, Jianwen He, Marco Ranucci, Massimiliano M. Corsi Romanelli |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-06-01
|
Series: | Biomolecules |
Subjects: | |
Online Access: | https://www.mdpi.com/2218-273X/12/6/826 |
Similar Items
-
Investigation of Plasma Presepsin (sCD14-ST) Levels in Sepsis
by: Alper TAHMAZ, et al.
Published: (2022-04-01) -
Evaluating the Roles of sCD14 and sCD14-ST in Diagnosing COPD and Predicting an Acute Exacerbation of COPD
by: Rui Zhang, et al.
Published: (2022-06-01) -
The accuracy assessment of presepsin (sCD14-ST) for mortality prediction in adult patients with sepsis and a head-to-head comparison to PCT: a meta-analysis
by: Zhu Y, et al.
Published: (2019-06-01) -
PRELIMINARY STUDY OF SCD14 AND SCD163 AS PREDICTORS OF DISEASE SEVERITY AND ICU ADMISSION IN COVID-19: RELATION TO HEMATOLOGICAL PARAMETERS, BLOOD MORPHOLOGICAL CHANGES AND INFLAMMATORY BIOMARKERS
by: hend Attia
Published: (2023-08-01) -
THE INFLUENCE OF CETIRIZINE ON THE CONCENTRATION OF sCD14 IN BLOOD OF THE CHILDREN WITH ATOPIC DERMATITIS
by: E.S. Nisheva, et al.
Published: (2006-01-01)